Objectives: Although dramatic improvements of overall survival has achieved in patients with favourable histology Wilms tumour, disease recurrence is still the main cause of cancer-related death in childhood. Long non-coding RNAs (lncRNAs) as oncogenes or tumour suppressors are dysregulated during carcinogenesis. However, the role of lncRNAs in the pathogenesis of Wilms tumour is unknown. Here, an lncRNA LINC00473 signature that functioned as oncogene was identified in Wilms tumour. 
| INTRODUCTION
As an embryonal type of renal cancer, Wilms' tumour (nephroblastoma) is the most common primary renal tumour occurring in childhood, which affects one in 10 000 children and accounts for 5% of all childhood cancers. 1, 2 In Asia, boys have a greater disease incidence than girls, and approximately 500 cases are identified each year in the United States. Due to the successive clinical trials conducted by the National Wilms Tumor Study Group (NWTSG), now the Children's Oncology Group (COG), the International Society of Pediatric Oncology (SIOP) and other national study groups, the overall survival (OS) rate of patients with Wilms tumour has risen to exceeding 90%, especially for those with favourable histology. However, the survival rate for patient with unfavourable histologic and molecular features (eg, diffuse and focal anaplasia or loss of heterozygosity (LOH) at chromosomes 1p and 16q) remains well below 90%, which is attributed to the increased risk of disease recurrence. 3, 4 Therefore, investigations on the molecular pathogenesis of Wilms tumour are conducive to improve the treatment and outcomes of patient with unfavourable histology.
In mammalian cells, the majority of transcribed RNAs are noncoding, which do not contain protein-coding sequences. These transcripts are eventually, on one hand, processed into small RNAs including microRNAs (miRNAs), Piwi-interacting RNAs (piRNAs), tRNA-derived stress-induced fragment RNAs and small nucleolar RNAs (snoRNAs), and, on the other hand, processed into long noncoding RNAs (lncRNAs). 5, 6 miRNAs are ~20-25 nucleotide non-coding RNAs which involve in post-transcriptional regulation of gene expression and present in almost all organisms including kidney. Yu et al found that miR-34a could directly target and impair the CD44 level in renal cancer cells to suppress renal cancer cell growth, tube formation and metastasis in vitro and in vivo. 7 miR-21 was reported to target PTEN in renal cancer cells and control the expression of cyclin D1
to promote proliferation through NF-κB-dependent transcription.
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Mounting evidences also demonstrated that lncRNAs were able to participate into a broad range of cellular processes of carcinogenesis, such as tumour cell growth, differentiation, metastasis and chemotherapy resistance. [9] [10] [11] [12] However, the bio-functions and molecular mechanisms of lncRNAs in Wilms' tumour remained largely unknown.
To be noted that the cross-regulation between microRNAs and lncRNAs is the important way for LncRNA to exert its function.
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LncARSR promoted sunitinib resistance via competitively binding 
| MATERIALS AND METHODS

| Tumour samples, cell lines and reagents
Wilms tumour tissues (n = 15) and corresponding relative normal tissues (n = 15) were collected from Guangzhou Women and Children's Medical
Center. All these retrospective specimens were handled according to 
| Cell transfection
The SK-NEP-1 cells were cultured to about 80% confluence in 6/12-well plates and then, using Lipofectamine 2000 (Invitrogen, USA), the cells were transfected with indicated agents according to the manufacturer's instructions. After transfection for the indicated time, the cells were harvested for further experiments.
| CCK-8 assay
The treated SK-NEP-1 cell lines were harvested and washed with PBS and then cell counting kit-8 (Kumamoto, Japan) mixed with DMEM was used for cell viability assay, and the absorbance was measured at 450 nm by a microplate reader.
| EdU assay
The treated SK-NEP-1 cell lines were treated with 50 μM of EdU for 2 hours at 37°C and harvested to be fixed with 4% formaldehyde in PBS for 10 minutes and rinsed with PBS for 3 times. Then, cells were permeabilized with 100% methanol for 10 min at −20°C. After that, the cells were treated with 1×Apollo reaction cocktail for 30 minutes, and the nuclei of the cells were stained with DAPI and visualized under a fluorescent microscope.
| Flow cytometer assay
For the cell cycle analysis, SK-NEP-1 cells were stained with PI staining solution (10 μg mL −1 RNase A and 50 μg mL −1 PI) at 37°C for 30 minutes in dark. The cell cycle distribution was analysed using a flow cytometry provided with the Cell-Quest software.
| Transwell assay
In the migration assay, 2 × 10 4 SK-NEP-1 cells transfected with indicated agents were in the upper chamber of a non-coated transwell insert, and in the invasion assay, the upper chamber of the transwell inserts was coated with Matrigel, and tumour cells were plated in the upper chamber of the Matrigel-coated transwell insert. Cells that did not migrate or invade were removed using a cotton swab and were stained by crystal violet and counted under an inverted microscope.
Five random views were selected to count the cells. 
| RNA isolation and qRT-PCR
| Western blotting
According to the manufacturer's instructions, proteins were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membrane (Bio-Rad, Hercules, CA, USA) and were blocked in 5% non-fat milk in TBST buffer (Tris Buffer Saline containing 0.1% Tween-20) for 1 h at room temperature, and subsequently incubated with primary antibodies overnight at 4°C.
After washing with TBST buffer, the blots were then incubated with HRP-conjugated secondary antibody for 1 hour at room temperature.
The blots were washed with TBST buffer and visualized using the ECL-Plus reagent (Millipore, Billerica, MA, USA). GAPDH was used as the loading control in the Western blotting.
| Luciferase reporter assay
The SK-NEP-1 cells were co-transfected containing psiCHECK2-miR-195, psiCHECK2-LINC00473-wild or mut, psiCHECK2-3′UTR
(wild or mut) of IKKα, pcDNA3.1-LINC00473 or miR-195 mimics.
Luciferase activity was measured using the Dual-Luciferase Reporter
Assay System (Promega, USA). Firefly luciferase acted as a reporter gene for normalized control.
| Immunohistochemistry
The expression of Ki-67, caspase-3 and cycling D1 in Wilms tumour tissues was analysed on 2 μm thick, formalin-fixed and paraffin-embedded specimen sections. Slides were incubated in xylene for 5 minutes and followed by 2 washes of 100% ethanol for 10 minutes, 95% ethanol for 10 minutes. Antigen unmasking was performed at room temperature. Then, the primary antibody incubated the FFPE specimen sections at 4°C overnight, and then the EnVision Detection System kit (DAKO, Denmark) was used for the DAB chromogen followed by nuclear staining using haematoxylin.
| Tumour model
To 
| Statistical analyses
| RESULTS
| Elevated LINC00473 expression correlated to higher stage and unfavourable histology in Wilms tumour
We investigated the clinical expression of LINC00473 in patients of Wilms tumour. Thus, Wilms tumour tissues (n = 15) and corresponding non-neoplastic tissues (n = 15) and the Q-PCR results showed that the LINC00473 level was significantly elevated in cancer tissues (Tumour) than that in the corresponding non-neoplastic tissue (Normal) ( Figure 1A ). Moreover, we analysed the correlations between the clinicopathological characteristics of Wilms tumour patients and LINC00473 expression. We found that patients with higher tumour stage and unfavourable histology harboured a significant higher LINC00473 level in tumour samples ( Figure 1A,B) . Thus, up-regulated LINC00473 expression might participate into the pathogenesis of Wilms tumour.
| LINC00473 promotes tumour growth and metastasis in vitro
High expression of LINC00473 was noticed to be associated with ( Figure 2F ). Besides, we found that knockdown of LINC00473 was able to repress the anti-apoptosis protein Bcl-2 level and promote the cleavage of caspase-3 for the induction of apoptosis. CDK2 and cyclin D1 were essential for the transition of G1/S cycle, but they were down-regulated by the siRNA-LINC00473 ( Figure 2G ). These results indicated that LINC00473 involved into the cell proliferation, apoptosis and migration in Wilms tumour.
| LINC00473 contains functional miR-195 interaction sites and inhibits miR-195 availability
We next analysed the molecular mechanism of LINC00473-related tu- ( Figure 3E ). Therefore, LINC00473 was able to sequester miR-195 to inhibit its function to increase Rluc expression.
| The anti-tumour role of miR-195 could be inhibited by up-regulated LINC00473
Due to the inhibition of LINC00473 to miR-195, we assessed the expres- 
| IKKα is a direct target of LINC00473/miR-195 signal axis
Amounting evidences indicated that IKKα was high expressed during the progression of cancer and involved into tumour growth and metastasis. 17, 18 MiR-195 was reported to target and inhibit the IKKα level in cancer, 19 thus we proposed a hypothesis that LINC00473 was 
| Knockdown of LINC00473 effectively promotes Wilms tumour regression in vivo
The pro-tumour effects of LINC00473 in vivo were determined, the 
| DISCUSSION
Wilms tumour accounts for approximately 90% of all paediatric tumours of the kidney, and currently, the overall survival rate of Wilms tumour has been improved to exceeding 90% in patients with favourable histology, which is attributed to the risk-stratification system based on patient age, tumour stage, tumour weight, histology and tumour-specific loss of heterozygosity (LOH) at chromosomes 1p and 16q
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. However, high-risk
Wilms tumour such as unfavourable histology or post-chemotherapy blastemal-type Wilms tumours still needs to identify novel molecules and therapies for stratification of treatment intensity. 20 In this study, we found that the LINC00473 level was elevated in higher stage and unfavourable histology Wilms tumour. We found that LINC00473 se- regulatory elements to promote tumorigenesis. 24 Lnc-ATB was the most remarkably up-regulated lncRNA in the tissues of breast cancer patients with trastuzumab resistance and could induce invasion-metastasis cascade in breast cancer. 25 We here in Wilms tumour found that LINC00473
promoted the cell proliferation, and its knockdown promoted Bcl-2-dependent apoptosis and G1/S arrest via CDK2 and cyclin D1. The interaction among mammalian lncRNAs and miRNAs was the important mechanism for lncRNA to exert its anti-or pro-tumour function. Zhuang et al found that H19 are precursors for the generation of miR-675 to target RUNX1, a well-known tumour suppressor, and involved into gastric cell carcinogenesis. 26 But, in turn, let-7 family functioned as miRNAtriggered lncRNA decay could target LincRNA-p21, HOTAIR and H19 to were determined by immunohistochemistry. *P < .05, **P < .01, data represent the mean ± SD degradation. 13 LncRNA as miRNA sponges was also an essential regulation way. 27 During the gastric carcinogenesis, the expression of HOTAIR was elevated and negatively correlated with miR-331. HOTAIR acts as a competing endogenous RNA (ceRNA) by binding miR-331 to abolish the miR-331-induced inhibition on HER2, leading to tumour growth through the Akt pathway. 28 Similarly, we here demonstrated that LINC00473 was able to sequester miR-195 to inhibit its function and decrease the miR-195 level; thus, the anti-tumour role of miR-195 was abrogated and activated IKKα-dependent cell proliferation and survival, which highlighted the miRNA regulation role of LncRNA in cancer.
In summary, we uncovered a dysregulated lncRNA signature LINC00473/miR-195/IKKα that functioned as pro-tumour pathogenesis in Wilms tumour and knockdown of LINC00473 could be an alternative therapy for the treatment of Wilms tumour.
